An Evaluation of Long-Term Survivors Treated for Cancer of the Esophagus with Preoperative X-Ray Therapy

Eq, Seymour; Pettit, Harold S.

doi:10.1148/106.2.423

Radiology

1973

DOI: 10.1148/106.2.423

|View full text |Cite

An Evaluation of Long-Term Survivors Treated for Cancer of the Esophagus with Preoperative X-Ray Therapy

Seymour Eq¹,

Harold S. Pettit²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1978

1986

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Subsequent upper aerodigestive malignancies following treatment of esophageal cancer

Fogel

Harrison

Son

1985

Cancer

View full text Add to dashboard Cite

One hundred ninety‐eight patients received radiation therapy for carcinoma of the esophagus. Eight patients subsequently developed at least one other epidermoid carcinoma within the upper aerodigestive tract. Analysis by life‐table method suggests a steadily increasing risk for second malignancies as survival lengthens. Implications with regard to the treatment and management of patients with squamous cell carcinoma of the esophagus are discussed and the relevant literature is reviewed.

show abstract

Subsequent upper aerodigestive malignancies following treatment of esophageal cancer

Fogel

Harrison

Son

1985

Cancer

View full text Add to dashboard Cite

show abstract

Measures for improving therapeutic results of esophageal carcinoma in stage III: Preoperative radiotherapy

Liu¹,

Huang²,

Rong³

et al. 1986

J. Surg. Oncol.

View full text Add to dashboard Cite

Surgical therapeutic results of esophageal carcinoma stage III in 245 cases admitted to our hospital from 1966 to 1982 are reported in this paper. In this series, 171 cases were treated by surgery alone and 74 cases treated with a combination of preoperative radiotherapy and surgery. Of the entire group, 184 cases underwent gastroesophagostomy or colon interposition for esophageal reconstruction preceded by resection of the cancerous esophageal segment. The resectability rate was 75.1%, and the resection operative mortality rate was 7.1%. The 5- and 10-year survival rates were 30.0 and 25.8%, respectively. In the group of 171 cases treated by surgery alone, the resectability rate was 73.1% (125/171), and the resectability in the middle third esophageal carcinoma was only 64.7% (44/68), while in the group of 74 cases treated by combination treatment, the resectability increased to 79.7% (59/74) and the resectability in the middle third esophageal carcinoma increased to 79.3% (46/58). The 5-year survival rate in the combination-therapy group (60.1%) was 42.9% higher than that of the group treated by surgery alone (17.2%) (p less than 0.01). However, the differences in the rates of resection operative mortality and operative complications between these two groups were not significant. Therefore, we think that preoperative radiotherapy for esophageal carcinoma in stage III is an effective measure for improving resectability and survival rate.

show abstract

Radiotherapy for esophageal carcinoma

Pearson

1981

World j. surg.

View full text Add to dashboard Cite

During the last 30 years, there have been improvements in radiotherapy not matched by improvements in earlier diagnosis. The screening program in the People's Republic of China is an exception. For lower incidence areas, greater patient and physician awareness and the addition of brushings, washings, and cytology to improved barium studies and endoscopy for the earlier investigation of dysphagia may contribute to earlier diagnosis and thus more effective radiotherapy. There are no experimental data to prove that either surgery or radiotherapy is preferable in the management of the various categories of esophageal cancer; however, close teamwork between the disciplines is fruitful. Neither radio‐therapy nor surgery for esophageal cancer is optimal in the hands of the occasional practitioner. In communities where radiotherapy and surgery are both highly developed and closely associated, optimal benefit is likely to be achieved if patients with squamous carcinoma of the middle and upper thirds of the esophagus are treated initially by radiotherapy with surgery held in reserve for local recurrences, and patients with squamous carcinoma of the lower third and all adenocarcinomas are treated surgically unless medically unfit. For the patients treated primarily by surgery, preoperative radiotherapy may help. Patients with more advanced disease can usually be helped by palliative radiotherapy, with intubation held in reserve until an adequate fluid diet can no longer be swallowed. Prevention is conceivable and would be unquestionably preferable.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

An Evaluation of Long-Term Survivors Treated for Cancer of the Esophagus with Preoperative X-Ray Therapy

Cited by 4 publications

References 0 publications

Subsequent upper aerodigestive malignancies following treatment of esophageal cancer

Subsequent upper aerodigestive malignancies following treatment of esophageal cancer

Measures for improving therapeutic results of esophageal carcinoma in stage III: Preoperative radiotherapy

Radiotherapy for esophageal carcinoma

Contact Info

Product

Resources

About